Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Cash from Operations (2024 - 2025)

Historic Cash from Operations for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to -$805000.0.

  • Kairos Pharma's Cash from Operations fell 37916.67% to -$805000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was -$5.3 million, marking a year-over-year change of. This contributed to the annual value of -$4.0 million for FY2024, which is 498271.6% down from last year.
  • As of Q2 2025, Kairos Pharma's Cash from Operations stood at -$805000.0, which was down 37916.67% from -$714000.0 recorded in Q1 2025.
  • In the past 5 years, Kairos Pharma's Cash from Operations ranged from a high of $36000.0 in Q1 2024 and a low of -$2.0 million during Q3 2024